Premenstrual Syndrome Treatment Market to Worth US$ 1,622.7 Million by 2027 | Industry CAGR of 3.99%

IMARC Group has recently released a new research study titled "Premenstrual Syndrome Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

What are the growth prospects of the premenstrual syndrome treatment industry?

The global premenstrual syndrome treatment market size reached US$ 1,287.9 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,622.7 Million by 2027, exhibiting a growth rate (CAGR) of 3.99% during 2022-2027.

What is a premenstrual syndrome treatment?

Premenstrual syndrome (PMS) is a term used to describe the psychological and physical symptoms that some women experience prior to their period, including irritability or anger, mood swings, depression, weariness, joint and muscle discomfort, acne flare-ups, stomach bloating, and sore breasts. It affects women with high-stress levels and depression while undergoing changes in hormonal levels. It occurs through chemical changes in the brain due to fluctuations of serotonin responsible for mood states, depression, and food cravings. It is also caused by smoking, consuming fatty food products, and a lack of physical activity and quality sleep. It negatively impacts other health problems, such as asthma, allergies, migraines, irritable bowel syndrome (IBS), myalgic encephalomyelitis (ME), and bladder pain syndrome (BPS). It can become severe by various hormonal disorders, such as endometriosis and polycystic syndrome (PCOS). PMS is treated by various medications, such as antidepressants, nonsteroidal anti-inflammatory drugs (NSAIDs), diuretics, and hormonal contraceptives. It can also be prevented by drinking herbal tea, eating a nutritious diet, and consuming folic acid, vitamin B-6, calcium, and magnesium supplements.

Impact of COVID-19:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request and get a sample brochure for free: https://www.imarcgroup.com/premenstrual-syndrome-treatment-market/requestsample

What are the major market drivers in the premenstrual syndrome treatment market?

One of the main factors driving the growth of the market is the increased prevalence of premenstrual dysphoric disorders (PMDD), such as headaches, insomnia, suicidal thoughts, and panic attacks, which are brought on by people's sedentary lifestyles. Besides this, the growing demand for ovarian suppression drugs to lower the amount of estrogen made by the ovaries is offering a positive market outlook. In addition, the increasing awareness about PMS symptoms and treatments among the masses worldwide is strengthening the market growth. Moreover, there is a rise in the demand for herbal medicines and vitamin supplements to treat PMS among women across the globe. This, coupled with the thriving healthcare industry, is strengthening the growth of the market. In line with this, key manufacturers are investing in research and development (R&D) activities to introduce medications with minimal side effects that aid in maintaining the appropriate pH balance in the body. Additionally, the escalating demand for organic chasteberry to treat anxiety, increase blood levels of progesterone, and reduce breast pain during the menstrual cycle is offering lucrative growth opportunities to industry investors. Apart from this, the rising utilization of smartphone applications to record physiological and emotional changes in patients and receive medication reminders by healthcare organizations is supporting the market growth. Furthermore, governing agencies of various countries are organizing campaigns to raise awareness about female health, which is contributing to the growth of the market.

Get the table of contents with all detailed information: https://www.imarcgroup.com/premenstrual-syndrome-treatment-market

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Drug Type:

Analgesics
Antidepressants
Oral Contraceptives and Ovarian Suppression Agents
Others

Breakup by Type:

Prescription
Prescription

Breakup by Distribution Channel:

Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Stores

By Geography:

North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

List of Major Key Players:

AbbVie Inc
BASF SE
Bayer AG
Reddy's Laboratories Ltd
Eli Lilly and Company
GlaxoSmithKline Plc
Lundbeck A/S
Pfizer Inc
SHIONOGI Co. Ltd

Related Report by IMARC Group:

Latin America Dry Eye Syndrome Market Report: https://www.imarcgroup.com/latin-america-dry-eye-syndrome-market

Behavioral Rehabilitation Market Report: https://www.imarcgroup.com/behavioral-rehabilitation-market

Protein Detection & Quantification Market Report: https://www.imarcgroup.com/protein-detection-quantification-market

Aerosol Delivery Devices Market Report: https://www.imarcgroup.com/aerosol-delivery-devices-market

Onychomycosis Treatment Market Report: https://www.imarcgroup.com/onychomycosis-treatment-market

Lateral Flow Assay Market Report: https://www.imarcgroup.com/lateral-flow-assay-market

Tissue Banking Market Report: https://www.imarcgroup.com/tissue-banking-market

Drug Device Combination Products Market Report: https://www.imarcgroup.com/drug-device-combination-products-market

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company's expertise.

This release was published on openPR.